Last $23.63 USD
Change Today -0.33 / -1.38%
Volume 63.3K
As of 11:57 AM 12/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael J. Pellini M.D., MBA

Chief Executive Officer, President and Director, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 14 board members in 3 different organizations across 7 different industries.

See Board Relationships
48$1,281,351
As of Fiscal Year 2013

Background*

Dr. Michael J. Pellini, M.D., MBA, Mike has been the Chief Executive Officer and President at Foundation Medicine, Inc. since May 12, 2011. Dr. Pellini has a breadth of experience in life sciences and the clinical diagnostics and laboratory industries. Dr. Pellini served as the President of Clarient, Inc. since April 28, 2008 and as its Chief Operating Officer since October 2007. While at Clarient, he worked with its leadership team to drive critical regulatory and reimbursement ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

President and Chief Executive Officer
Member of Executive Committee of the Board of Trustees
Director
2007-2009
Former President and Chief Operating Officer
2007-N/A
Former Director
2011-Present
Chief Executive Officer, President and Director

Education*

MBA
Drexel University
BA
Boston College
MD
Thomas Jefferson University
MD
Thomas Jefferson University School Of Medicine

Other Affiliations*

Annual Compensation*

Salary$403,887
Total Annual Compensation$403,887

Stock Options*

All Other Compensation$75,850
Exercisable Options165,655
Exercisable Options Value$3,752,291
Unexercisable Options255,252
Unexercisable Options Value$5,080,152
Total Value of Options$8,832,442
Total Number of Options420,907

Total Compensation*

Total Annual Cash Compensation$675,025
Total Short Term Compensation$403,887
Other Long Term Compensation$75,850
Total Calculated Compensation$1,281,351
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FMI:US $23.63 USD -0.33

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.